Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan 14;4(3):355-370.
doi: 10.1002/hep4.1457. eCollection 2020 Mar.

Hepatitis C Virus Prevalence in 50 U.S. States and D.C. by Sex, Birth Cohort, and Race: 2013-2016

Heather Bradley  1 , Eric W Hall  2 , Elizabeth M Rosenthal  3 , Patrick S Sullivan  2 , A Blythe Ryerson  4 , Eli S Rosenberg  3
Affiliations

Hepatitis C Virus Prevalence in 50 U.S. States and D.C. by Sex, Birth Cohort, and Race: 2013-2016

Heather Bradley et al. Hepatol Commun. .

Abstract

Hepatitis C virus (HCV) infection is a leading cause of liver-related morbidity and mortality, and more than 2 million adults in the United States are estimated to be currently infected. Reducing HCV burden will require an understanding of demographic disparities and targeted efforts to reduce prevalence in populations with disproportionate disease rates. We modeled state-level estimates of hepatitis C prevalence among U.S. adults by sex, birth cohort, and race during 2013-2016. National Health and Nutrition Examination Survey data were used in combination with state-level HCV-related and narcotic overdose-related mortality data from the National Vital Statistics System and estimates from external literature review on populations not sampled in the National Health and Nutrition Examination Survey. Nationally, estimated hepatitis C prevalence was 1.3% among males and 0.6% among females (prevalence ratio [PR] = 2.3). Among persons born during 1945 to 1969, prevalence was 1.6% compared with 0.5% among persons born after 1969 (PR = 3.2). Among persons born during 1945 to 1969, prevalence ranged from 0.7% in North Dakota to 3.6% in Oklahoma and 6.8% in the District of Columbia. Among persons born after 1969, prevalence was more than twice as high in Kentucky, New Mexico, Oklahoma, and West Virginia compared with the national average. Hepatitis C prevalence was 1.8% among non-Hispanic black persons and 0.8% among persons of other races (PR = 2.2), and the magnitude of this disparity varied widely across jurisdictions (PR range: 1.3-7.8). Overall, 23% of prevalent HCV infections occurred among non-Hispanic black persons, whereas 12% of the population was represented by this racial group. These estimates provide information on prevalent HCV infections that jurisdictions can use for understanding and monitoring local disease patterns and racial disparities in burden of disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Analytic steps and data sources used to estimate state‐level HCV prevalence by age, race, and sex.
Figure 2
Figure 2
Estimated hepatitis C prevalence by sex compared with state‐level population distribution by sex.
Figure 3
Figure 3
Estimated hepatitis C prevalence by birth cohort compared with state‐level population distribution by birth cohort.
Figure 4
Figure 4
Estimated hepatitis C prevalence by race compared with state‐level population distribution by race.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Centers for Disease Control and Prevention . Surveillance for Viral Hepatitis—United States, 2016. Updated 2017. https://www.cdc.gov/hepatitis/statistics/2016surveillance/commentary.htm. Accessed January 1, 2018.
    1. Chhatwal J, Chen Q, Aggarwal R. Estimation of hepatitis C disease burden and budget impact of treatment using health economic modeling. Infect Dis Clin North Am 2018;32:461‐480. - PubMed
    1. Wong JB, McQuillan GM, McHutchison JG, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000;90:1562‐1569. - PMC - PubMed
    1. Denniston MM, Klevens RM, McQuillan GM, Jiles RB. Awareness of infection, knowledge of hepatitis C, and medical follow‐up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001‐2008. Hepatology 2012;55:1652‐1661. - PMC - PubMed
    1. Smith BD, Morgan RL, Beckett GA, Falck‐Ytter Y, Holtzman D, Teo CG, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945‐1965. MMWR Recomm Rep 2012;61:1‐32. - PubMed